MedTrace Logo

AVERT Plus Post-Market Registry

NCT02436642 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-05-19

No results posted yet for this study

Summary

The devices used in this observational registry are the Osprey Medical Contrast Monitoring System (CMS) and the Osprey Medical AVERT Reflux Reduction System. Both products have CE Mark designations. The purpose of this registry is to evaluate the usability characteristics of the combined Osprey Medical AVERT System and the Contrast Monitoring System during normal clinical use.

Conditions

Interventions

DEVICE

AVERT Plus System

Sponsors & Collaborators

  • Osprey Medical, Inc

    lead INDUSTRY

Principal Investigators

  • Steffen Desch, MD · Universitatsklinikum Schleswig-Holstein (Campus Lubeck)

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02436642 on ClinicalTrials.gov